Master this deck with 21 terms through effective study methods.
Generated from uploaded pdf
Hepatitis B virus (HBV) is primarily transmitted through sexual contact, exposure to infected blood, and from mother to infant during childbirth. It can be found in semen and vaginal secretions, as well as in the blood of infected individuals.
The key phases of HBV infection include the prodromal phase, where symptoms like fever and malaise occur; the icteric phase, characterized by jaundice and dark urine; and the convalescent phase, where recovery begins. Fulminant hepatitis can occur in about 1% of cases, leading to severe symptoms and potential fatality.
HBV replicates in liver cells after entering the bloodstream. It is secreted from hepatocytes into circulation and can infect neighboring hepatocytes, leading to liver damage and an immune response from B and T cells.
HBsAg (Hepatitis B surface antigen) indicates active HBV infection, while HBeAg (Hepatitis B e antigen) suggests high levels of viral replication and infectivity. The presence of both indicates a higher risk of transmission and liver damage.
Outcomes of HBV infection can range from acute hepatitis, which may be asymptomatic, to chronic hepatitis, which occurs in 5-10% of adults and 20-50% of children under 6 years. Chronic infection can lead to liver cirrhosis, liver cancer, and a mortality rate of 15-25% in chronic carriers.
The incubation period for Hepatitis B virus (HBV) is typically 10 to 12 weeks, but it can often range from 2 to 3 months before symptoms appear.
Prevention strategies for HBV include active immunization with vaccines such as Recombivax and Engerix-B, which are administered in three doses. Twinrix combines protection against both HBV and HAV. New vaccines like PreHevbrio have also been approved.
Hepatitis C virus (HCV) is a spherical, enveloped virus belonging to the Hepacivirus genus within the Flavivirus family. It has a diameter of 30-60 nm and contains a single-stranded RNA genome, along with structural proteins (C, E1, E2) and nonstructural proteins (NS2, NS3, NS4A, NS4B, NS5A, NS5B).
HCV evades the immune system by lacking 3′-5′ exonuclease activity, which means it has no proofreading ability, leading to high mutation rates in its envelope proteins. This antigenic variation allows multiple subspecies to coexist in an infected individual.
Common transmission routes for Hepatitis C virus (HCV) include transfusions of blood or plasma products, sharing of contaminated needles and equipment among injection drug users, and, less commonly, sexual intercourse and mother-to-infant transmission.
Clinical manifestations of hepatitis include inflammation and damage to the liver, leading to symptoms such as fever, malaise, anorexia, nausea, vomiting, abdominal pain, jaundice, and increased serum levels of liver enzymes.
Serological tests are crucial for diagnosing hepatitis as they detect specific antibodies or antigens in the blood, helping to identify the type of hepatitis virus present and the stage of infection.
Acute hepatitis is a short-term illness that can resolve on its own, often with mild or no symptoms, while chronic hepatitis persists for six months or longer and can lead to serious complications such as cirrhosis and liver cancer.
Hepatitis A virus (HAV) is a non-enveloped, single-stranded RNA virus belonging to the Picornavirus family. It is approximately 27 nm in size and is primarily transmitted through the fecal-oral route, often via contaminated food or water.
The Australia antigen, also known as HBsAg, is a marker of HBV infection. Its presence indicates active viral replication and is used to assess the infectivity of an individual.
Complications of chronic hepatitis can include liver cirrhosis, hepatocellular carcinoma (liver cancer), liver failure, and increased risk of other liver-related diseases.
The immune response to HBV infection involves the activation of B and T cells, which can lead to the clearance of the virus in some individuals. However, in chronic cases, the immune response may be insufficient to eliminate the virus, resulting in ongoing liver damage.
Antiviral drugs target specific nonstructural proteins of HCV, such as NS3/4A protease and NS5B RNA-dependent RNA polymerase, to inhibit viral replication and improve treatment outcomes for infected individuals.
Risk factors for developing chronic hepatitis B include being infected at a young age (especially newborns), having a compromised immune system, and engaging in high-risk behaviors such as unprotected sex or sharing needles.
Hepatitis viruses pose a significant public health challenge due to their potential for widespread transmission, chronic infection rates, and the risk of severe liver disease, necessitating effective prevention, vaccination, and treatment strategies.
Hepatitis B is primarily transmitted through sexual contact and blood exposure, while Hepatitis C is most commonly transmitted through sharing contaminated needles and blood products. Sexual transmission of HCV is less common compared to HBV.